We previously discovered distinct variations in the intestinal microbiota and metabolites corresponding to the outcome of angiotensin‐converting enzyme inhibitors and ARB treatment [19]; however, whether the gut microbiome in patients with WC hypertension contributes to its antihypertensive effect has not been systematically elucidated. Here, ACE is linked to hypertensive disorder.